PamelaLZeitlinMD

PubMed

• 3 citations
  Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro.
  Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
  Journal of Cystic Fibrosis. 2022-07-01
• In Response.
  Amy J Lee, Julie L Huffmyer, Eryn L Thiele, Pamela L Zeitlin, Debnath Chatterjee
  Anesthesia and Analgesia. 2022-07-01
• The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.
  Amy J Lee, Julie L Huffmyer, Eryn L Thiele, Pamela L Zeitlin, Debnath Chatterjee
  Anesthesia and Analgesia. 2022-06-01

Journal Articles

• Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children  
  Shen, Y, Liu, J, Zhong, L, Mogayzel, PJ, Zeitlin, PL, Sosnay, PR, and Zhao, S, J Pediatr., 1/1/2016
• Use of ibuprofen to assess inflammatory biomarkers in induced sputum: Implications for clinical trials in cystic fibrosis  
  Chmiel JF, Konstan MW, Accurso FJ, Lymp J, Mayer-Hamblett N, VanDevanter DR, Rose LM, Ramsey BW; Assessment of Induced Sputum in Cystic Fibrosis Study Group, J Cyst Fibros, 1/1/2015
• Interference with ubiquitination in CFTR modifies stability of core glycosylated and cell surface pools  
  Lee S, Henderson MJ, Schiffhauer E, Despanie J, Henry K, Kang PW, Walker D, McClure ML, Wilson L, Sorscher EJ, Zeitlin PL, Mol Cell Biol., 1/8/2014
• Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis  
  Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESC..., Pediatr Pulmonol, 1/1/2013
• Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelial  
  Schiffhauer, E, Vij N, Kovbasnjuk, O, Kang PW, Walker D, Lee S, Zeitlin, PL, Am J Physiol Lung Cell Mol Physiol, 1/1/2013
• Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis  
  Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW; EPIC Investigators (Zeitlin PL), Pediatr Pulmonol, 1/1/2012
• Etiology of bronchodpulmonary dysplasia: before birth  
  Zeitlin, PL and L. Nogee, Ped Allergy Immunol Pulmonol, 1/1/2011
• Highlights from the latest articles in cystic fibrosis clinical and translational sciences  
  Zeitlin PL, Therapy, 1/1/2011
• Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis  
  Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, ..., Arch Pediatr Adolesc Med., 1/1/2011
• Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function  
  Accurso FJ, Moss RB, Wilmott RW, Anbar RD, Schaberg AE, Durham TA, Ramsey BW; TIGER-1 Investigator Study Group (Zeitlin PL), Arch Pediatr Adolesc Med, 1/1/2011
• Ubiquitin C-terminal Hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation  
  Henderson, MJ, Vij N, and Zeitlin, PL, J. Biol. Chem., 1/1/2010
• Applications of proteomic technologies for understanding the premature proteolysis of CFTR  
  Henderson, MJ, Singh, OV, and Zeitlin, PL, Expert Rev. Proteomics, 1/1/2010
• Elevated serum IL-8 levels in ataxia telangiectasia  
  McGrath-Morrow SA, Collaco JM, Crawford TO, Carson KA, Lefton-Greif MA, Zeitlin P, Lederman HM, J Pediatr., 1/1/2010
• Genetic Modifiers of Liver Disease in Cystic Fibrosis  
  Bartlett JL, Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille..., JAMA, 1/9/2009
• CFTR is a negative regulator of NFKbeta mediated innate immune response  
  Vij, N, Mazur, S, and Zeitlin, PL, PLoS ONE, 1/1/2009
• Proteome of synatptosome-associated proteins in spinal cord dorsal horn after peripheral nerve injury  
  Singh, OV, Yaster M, Xu, JT, Guan Y, Guan X, Dhamarajan AM, Raja SN, Zeitlin PL and Tao, YX, Proteomics, 1/1/2009
• Spiperone, Identified through Compound Screening, Activates Calcium Dependent Chloride Secretion in the Airway  
  Liang L, Macdonald KD, Schwiebert EM, Zeitlin PL, Guggino WB, Am J Physiol Cell Physiol, 1/1/2009
• Pseudomonas aeruginosa: can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conduc...  
  Zeitlin PL, Am J Physiol Cell Physiol, 1/1/2009
• Lubiprostone activates non-CFTR dependent respiratory epithelial chloride secretion in cystic fibrosis mice  
  MacDonald, KD, McKenzie, KR, Henderson, MJ, Hawkins, CE, Vij, N, and Zeitlin, PL, J Physiol Lung Cell Mol Physiol, 1/1/2008
• Cystic fibrosis presenting as recurrent pancreatitis in a young child with a normal sweat test and pancreas divisum: a case report  
  Conklin, L, Zeitlin, PL, and Cuffari, C, J. Med. Case Reports, 1/1/2008
• Atypical cystic fibrosis and CFTR related diseases (Review)  
  Paranjape, SM, and Zeitlin, PL, Clin Rev Allergy Immunol, 1/1/2008
• Patients with mutations in Gsalpha have reduced activation of a downstream target in epithelial tissues due to haploinsufficiency  
  Hsu, SC, Groman JD, Merlo CA, Naughton K, Zeitlin PL, Germain-Lee EL, Boyle MP, and GR Cutting, J. Clin. Endocrin. Metab., 1/24/2007
• CHOP Transcription Factor Mediates IL-8 Signaling in Cystic Fibrosis Bronchial Epithelial Cells  
  Vij, N, Amoako MO, Mazur S, and PL Zeitlin, Am J Respir Cell Mol Biol., 1/20/2007
• Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation  
  MacDonald KM, McKenzie K and PL Zeitlin, Paediatr Drugs, 1/1/2007
• Emerging drug treatments for cystic fibrosis  
  Zeitlin PL, Expert Opin. Emerging Drugs, 1/1/2007
• Join now to see all

Books/Book Chapters

• Kendig and Chernicks’ Disorders of the Respiratory Tract in Children 
  Chapter: Genetics and Pathophysiology of cystic fibrosis 
  Page 753 - 763Cutting, GR, Zeitlin, PLEditors: Wilmott.Elsevier SaundersEdition 8th,2012
• Clinics in Chest Medicine - Cystic Fibrosis 
  Chapter: Therapies Directed at the Basic Defect in Cystic Fibrosis 
  Page 515 - 525Zeitlin PLEditors: Fiel.W.B. Saunders, Phila., PA1998
• Gene Therapy for Diseases of the Lung 
  Chapter: Adeno-associaed viral vectors 
  Page 53 - 81Zeitlin PLEditors: Brigham KL.Marcel Dekker Inc., New York, NY1997
• Les medicaments de la mucoviscidose chez l'enfant 
  Chapter: Pharmacological Approaches to Correct Defective CFTR Function 
  Page 155 - 164Zeitlin PL, and Guggino WBEditors: Pons G, Lenoir G, and Navarro J.Springer-Verlag, Paris Franc1997
• Critical Heart Disease in Infants 
  Chapter: Cor Pulmonale 
  Page 925 - 936Zeitlin PLEditors: Nichols DE, Cameron DE, Greeley WJ, Lappe DG, Ungerleider RM, and Wetzel RC.Mosby, St. Louis, MO1995
• Respiratory Disease in Children 
  Chapter: Pleural effusions and empyema 
  Page 453 - 463Zeitlin PLEditors: Eigen H, and Loughlin GM.Williams and Wilkins, Baltimore, MD1994
• Join now to see all

Lectures

• Managing Cystic Fibrosis in Adolescents and Young Adults 
  U. of Nevada, Las Vegas, NV - 1/13/2015
• Cystic Fibrosis 
  Beijing China, 2013; Fort Lauderdale, FL, 2014; Tawam Hospital, Al Ain, UAE, 2014 - 1/9/2014
• Pro Con Debate: Use of regular thoracic CT and bronchoscopy to care for early CF lung disease 
  San Diego, CA - 1/1/2014
• Non-invasive Ventilation Workshop 
  Tawam Hospital, Al Ain, U.A.E. - 1/1/2014
• Dean’s Lecture 
  The Johns Hopkins School of Medicine - 1/13/2013
• Update on Asthma 
  Beijing China - 1/9/2013
• Chronic Cough 
  Yuying Children’s Hospital, Wenzhou, China - 1/31/2011
• Role of UCH-L1 in CFTR Processing 
  Lucerne, Switzerland - 1/21/2010
• Controlling Pseudomonas Aeruginosa Infections: Lessons learned from the cystic fibrosis patient 
  Beijing Children’s Hospital, Beijing, China - 1/11/2009
• Asthma 
  Yuying Children’s Hospital, Wenzhou, China - 1/8/2009
• Targeting CFTR for the Cure 
  Childrens Hospital of LA - 1/6/2009
• Clinical Proteomics: i.e. Cystic Fibr’omics 
  Bethesda, MD - 1/21/2006
• Repair of chloride channel defects in CF 
  University of Pennsylvania - 1/1/2006
• Cystic Fibrosis Management: State of the Art 
  Geneva, Switzerland - 1/1/2005
• What Should Anesthesiologists Know about Cystic Fibrosis? 
  Geneva, Switzerland - 1/1/2005
• Protein Processing and Degradation 
  Cincinnati, OH - 1/26/2004
• Pharmacologic Approaches to CFTR Misfolding 
  Rockville MD - 1/5/2004
• Proteomics for Cystic Fibrosis 
  Paris, France - 1/9/2003
• New Therapies for Cystic Fibrosis 
  Marco Island, FL, 2002; Verona, Italy, 2003 - 1/8/2002
• Update on New Diagnostic Methods and Therapies for Cystic Fibrosis 
  1/12/1999
• Pharmacologic Therapy for Cystic Fibrosis 
  Case Western Reserve University, Cleveland OH - 1/11/1999
• Restoration of chloride transport in Cystic Fibrosis epithelial by sodium 4-phenylbutyrate 
  Jerusalem, Israel - 1/21/1998
• Strategies to Correct the CFTR Defect 
  Paris, France - 1/20/1997
• Phenylbutyrate 
  Williamsburg, VA - 1/1/1997
• What's new in Asthma? 
  San Antonio, TX - 1/1/1997
• Join now to see all